
==== Front
J Transl Med
J Transl Med
Journal of Translational Medicine
1479-5876
BioMed Central London

37996876
4661
10.1186/s12967-023-04661-y
Research
Parathyroid hormone stimulates bone regeneration in an atrophic non-union model in aged mice
http://orcid.org/0000-0002-1261-9877
Menger Maximilian M. maximilian.menger@uks.eu

12
Tobias Anne L. 2
Bauer David 2
Bleimehl Michelle 2
Scheuer Claudia 2
Menger Michael D. 2
Histing Tina 1
Laschke Matthias W. 2
1 https://ror.org/03a1kwz48 grid.10392.39 0000 0001 2190 1447 Department of Trauma and Reconstructive Surgery, Eberhard Karls University Tuebingen, BG Trauma Center Tuebingen, 72076 Tuebingen, Germany
2 https://ror.org/01jdpyv68 grid.11749.3a 0000 0001 2167 7588 Institute for Clinical and Experimental Surgery, Saarland University, 66421 Homburg/Saar, Germany
23 11 2023
23 11 2023
2023
21 84421 8 2023
26 10 2023
© The Author(s) 2023, corrected publication 2024
2023
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background

Non-union formation still represents a major burden in trauma and orthopedic surgery. Moreover, aged patients are at an increased risk for bone healing failure. Parathyroid hormone (PTH) has been shown to accelerate fracture healing in young adult animals. However, there is no information whether PTH also stimulates bone regeneration in atrophic non-unions in the aged. Therefore, the aim of the present study was to analyze the effect of PTH on bone regeneration in an atrophic non-union model in aged CD-1 mice.

Methods

After creation of a 1.8 mm segmental defect, mice femora were stabilized by pin-clip fixation. The animals were treated daily with either 200 μg/kg body weight PTH 1–34 (n = 17) or saline (control; n = 17) subcutaneously. Bone regeneration was analyzed by means of X-ray, biomechanics, micro-computed tomography (µCT) imaging as well as histological, immunohistochemical and Western blot analyses.

Results

In PTH-treated animals bone formation was markedly improved when compared to controls. This was associated with an increased bending stiffness as well as a higher number of tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts and CD31-positive microvessels within the callus tissue. Furthermore, PTH-treated aged animals showed a decreased inflammatory response, characterized by a lower number of MPO-positive granulocytes and CD68-positive macrophages within the bone defects when compared to controls. Additional Western blot analyses demonstrated a significantly higher expression of cyclooxygenase (COX)-2 and phosphoinositide 3-kinase (PI3K) in PTH-treated mice.

Conclusion

Taken together, these findings indicate that PTH is an effective pharmacological compound for the treatment of non-union formation in aged animals.

Keywords

Non-union
Parathyroid hormone
Segmental defect
Bone regeneration
Fracture healing
Angiogenesis
Mice
Aging
Inflammation
Universität des Saarlandes (1036)Open Access funding enabled and organized by Projekt DEAL.

issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2023
==== Body
pmcIntroduction

Despite increasing insights into the molecular and cellular mechanisms of fracture repair, non-union formation remains a major complication in orthopedic and trauma surgery [1]. In clinical practice, the treatment of non-unions is highly challenging and requires extensive revision surgery. Thus, non-union formation is not only associated with significant pain, loss of function and prolonged rehabilitation, but causes also a substantial economic burden for the health care system [2].

Due to the fact that the aged population is steadily increasing worldwide, the treatment of geriatric patients has become one of the major challenges in clinical practice [3]. The process of bone repair in the elderly is subject to physiological alterations, including decreased differentiation and proliferation of stem cells [4, 5] as well as delayed chondrogenesis and osteochondral ossification [6]. Accordingly, numerous clinical studies have reported that the aged population is at an increased risk for delayed fracture healing and non-union formation [7, 8]. To overcome this problem, there is a substantial need for the development of effective treatment strategies.

Parathyroid hormone (PTH), a peptide hormone secreted by the parathyroid glands, is a key regulator of calcium hemostasis in the body [9]. PTH raises the serum calcium levels by stimulating the reabsorption of calcium in the kidney and by stimulating osteoclast differentiation and proliferation, leading to osteoclastic bone resorption and calcium release from bone [10]. Moreover, PTH is the only clinically approved drug for the treatment of osteoporosis in the elderly. Of interest, several experimental studies demonstrated that PTH accelerates fracture healing [11–13] and stimulates bone regeneration in bone defects [14]. However, it is not known whether PTH also promotes the healing of atrophic non-unions in the aged.

To clarify this we analyzed in the present study, the effects of PTH treatment on atrophic non-unions using a well-established and reliable non-union model in aged CD-1 mice [15]. Bone regeneration was analyzed by means of X-ray, biomechanics, micro-computed tomography (µCT) imaging as well as histological, immunohistochemical and Western blot analyses.

Materials and methods

Animals

A total number of 34 male and female CD-1 mice with a body weight of 35–45 g and an age of 18–20 months were used. The age of 18–20 months was chosen according to reports of others, demonstrating age-associated physiological alterations and tumor development after 16–18 months in male and 18 months in female CD-1 mice [16]. The animals were bred at the Institute for Clinical and Experimental Surgery, Saarland University, Germany, and housed at a regular light and dark cycle with free access to tap water and standard pellet food (Altromin, Lage, Germany).

All experiments were performed according to the German legislation on the protection of animals and the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Research Council, Washington DC, USA). The experiments were approved by the local governmental animal protection committee (permit number: 04/2019).

Surgical procedure

Mice were anesthetized by intraperitoneal (i.p.) injection of ketamine (75 mg/kg body weight, Ursotamin®, Serumwerke Bernburg, Bernburg, Germany) and xylazine (15 mg/kg body weight, Rompun®, Bayer, Leverkusen, Germany). The pin-clip model using a segmental defect served as control and was performed as described previously [15]. Under aseptic conditions, a ~ 4 mm medial parapatellar incision was created at the right knee and the patella was dislocated laterally. After drilling a hole (diameter of 0.50 mm) into the intracondylar notch, a distally flattened pressfit 24 Gauge needle (diameter of 0.55 mm) was implanted intramedullary and the wound was closed. The pin was flattened at the distal end to avoid secondary dislocation. After insertion of the pin, the diaphysis of the femur was exposed by a lateral approach. Subsequently, a custom-made clip of 6 mm length was implanted ventrodorsally into the femur and lateral of the already implanted pin. A gap size of 1.8 mm was created by means of a spherical trephine under permanent saline solution cooling. Moreover, the periosteum was stripped 2 mm proximally and distally of the gap along the longitudinal axis of the femoral bone. The implant position was confirmed by radiography (MX-20, Faxitron X-ray Corporation, Wheelin, IL, USA). All procedures were done under an operating microscope, guaranteeing a high level of precision. For analgesia the mice received tramadol-hydrochloride (Grünenthal, Aachen, Germany) in the drinking water (1 mg/mL) 1 day prior to surgery until 3 days after surgery.

Experimental protocol

Seventeen mice were daily treated with 200 μg/kg body weight PTH 1–34 (Bachem AG, Budendorf, Switzerland) dissolved in 100 µL saline, subcutaneously (PTH group). Control animals (n = 17) received an equal amount of saline (control group), subcutaneously. The used PTH dosage corresponds to other experimental studies investigating the effects of PTH on fracture healing in mice [13]. At 2 weeks [n = 5 each group (3 male; 2 female)] and 10 weeks [n = 9 each group (5 male; 4 female)] the animals were euthanized by an overdose of anesthetics and the femora were excised for further µCT and histological analyses. Additional animals were euthanized accordingly at 2 weeks [n = 3 each group (2 male; 1 female)] and tissue was harvested for Western blot analyses.

X-ray analysis

At 2 and 10 weeks after surgery the animals were anesthetized and lateral radiographs of the osteotomized femora were performed. Bone healing was analyzed according to the Goldberg score with stage 0 indicating radiological non-union, stage 1 indicating possible union and stage 2 indicating radiological union [17].

µCT analysis

The specimens were scanned (Skyscan 1176, Bruker, Billerica, MA) at a spatial resolution of 9 μm with a standardized setup (tube voltage: 50 kV; current: 200 µA; intervals: 0.4°; exposure time: 3500 ms; filter: 0.5 mm aluminum). Images were stored in three-dimensional arrays. To express gray values as mineral content (bone mineral density; BMD), calcium hydroxyapatite (CaHA) phantom rods with known BMD values (0.250 and 0.750 g CaHA/cm3) were employed for calibration. The region of interest (ROI) defining the novel bone was contoured manually excluding any original cortical bone. The thresholding allowed the differentiation between poorly and highly mineralized bone. The threshold to distinguish between poorly and highly mineralized bone was based upon visual inspection of the images, qualitative comparison with histological sections and other studies investigating bone repair and callus tissue by µCT [18, 19]. A BMD with more than 0.642 g/cm3, resulting in gray values of 98–255, was defined as highly mineralized bone. Poorly mineralized bone was assumed to have a BMD value between 0.410 g/cm3 and 0.642 g/cm3, resulting in gray values of 68–97.

The following parameters were calculated from the callus region of interest for each specimen: poorly mineralized bone volume (PM), highly mineralized bone volume (HM), bone volume fraction of tissue volume (BV/TV), bone surface (BS) density (BS/TV), trabecular thickness, trabecular separation and trabecular number.

Biomechanical analysis

After removal of the soft tissue and the implants, the bending stiffness of the isolated femora was measured by a 3-point-bending device using a non-destructive approach. This allowed the subsequent use of the specimens for µCT as well as histological and immunohistochemical analyses and, thus, a reduction of the number of laboratory animals. Due to the different stages of healing, the loads, which had to be applied, markedly varied between individual animals. Loading was stopped individually in every case when the actual load-displacement curve deviated more than 1% from linearity. Bending stiffness (N/mm) was calculated from the linear elastic part of the load-displacement diagram [20].

Histology and histomorphometry

After biomechanical testing and µCT analysis, bones were fixed in paraformaldehyde for 24 h. Subsequently, the specimens were embedded in a 30% sucrose solution for another 24 h and then frozen at − 80° C. Longitudinal sections through the femoral axis with a thickness of 4 μm were cut by the Kawamotos film method [21, 22] for histomorphometric analyses and stained with Safranin-O. At a magnification of 12.5× (Olympus BX60 Microscope, Olympus, Shinjuku, Japan; Zeiss Axio Cam and Axio Vision 3.1, Zeiss) structural indices were calculated according to the recommendations of Gerstenfeld et al. [23]. The following histomorphometric parameters of the bone defects were evaluated: (i) total callus area, (ii) bone callus area, (iii) cartilaginous callus area and (iv) fibrous callus area. The total callus area was defined as the entire osseous, cartilaginous and fibrous callus tissue between the two drilling holes of the clip outside of the cortices. Pre-existing cortical bone of the proximal and distal fragment, however, was excluded. Each area was marked and calculated using the ImageJ analysis system (NIH, Bethesda, USA).

In addition, tartrate-resistant acid phosphate (TRAP) activity was analyzed in the callus tissue at 2 and 10 weeks after surgery. For this purpose, longitudinal sections of 4 μm were incubated in a mixture of 5 mg naphotol AS-MX phosphate and 11 mg fast red TR salt in 10 mL 0.2 M sodium acetate buffer (pH 5.0) for 1 h at 37 °C. Sections were counterstained with methyl green and covered with glycerin gelatin. TRAP-positive multinucleated cells (three or more nuclei each cell) were counted. In the specimens, one high-power field (HPF, 400× magnification) was placed in a standardized manner in the central region of the callus, while three additional HPFs were placed on each site of the periosteal callus.

Immunohistochemistry

To analyze the cellular composition within the callus tissue of atrophic non-unions at 2 and 10 weeks after surgery, longitudinal sections with a thickness of 4 μm were cut. For the immunohistochemical detection of microvessels, sections were stained with a monoclonal rat anti-mouse antibody against the endothelial cell marker CD31 (1:100; Abcam, Cambridge, UK). A goat anti-rat IgG-Alexa555 antibody served as secondary antibody (1:100; Life Technology, Eugene, USA). Cell nuclei were stained with Hoechst 33342 (2 µg/mL; Sigma-Aldrich, Taufkirchen Germany). To detect the neutrophilic granulocyte marker myeloperoxidase (MPO) and the macrophage marker CD68, sections were stained with a polyclonal rabbit anti-mouse antibody against MPO (1:100; Abcam) and a polyclonal rabbit anti-mouse antibody against CD68 (1:100; Abcam). A goat anti-rabbit IgG-antibody (1:200; Dianova, Hamburg, Germany) served as corresponding secondary antibody.

In the specimens, the number of CD31-positive microvessels as well as MPO- and CD68-positive cells was counted. For this purpose, one HPF was placed in a standardized manner in the central region of the callus, while three additional HPFs were placed on each site of the periosteal callus.

Western blot analysis

Protein expression within the callus tissue was determined by Western blot analysis, including the expression of vascular endothelial growth factor (VEGF), cyclooxygenase (COX)-2 and phosphoinositide 3-kinase (PI3K). The callus tissue was frozen and stored at − 80 °C until required. Analyses were performed from callus tissue at 2 weeks after surgery (n = 3 each group). After saving the whole protein fraction, analysis was performed using the following antibodies: rabbit anti-mouse VEGF (1:300, Abcam, Cambridge, UK), COX-2 (1:30, Abcam) and mouse anti-mouse PI3K (1:100, Santa Cruz Biotechnology, Heidelberg, Germany). Primary antibodies were followed by corresponding horseradish peroxidase-conjugated secondary antibodies (1:1000, R&D Systems). Protein expression was visualized by means of luminol-enhanced chemiluminescence after exposure of the membrane to the Intas ECL Chemocam Imager (Intas Science Imaging Instrument GmbH, Göttingen, Germany) and normalized to β-actin signals (1:1000, mouse anti-mouse β-actin, Santa Cruz Biotechnology) to correct for unequal loading.

Statistical analysis

All data are given as means ± SEM. After testing the data for normal distribution (Kolmogorov–Smirnov test) and equal variance (F-test), comparisons between the two groups were performed by an unpaired Student’s t‐test. For non‐parametrical data, a Mann–Whitney U‐test was used. All statistics were performed using the SigmaPlot 13.0 software (Jandel Corporation, San Rafael, CA, USA). A p‐value of < 0.05 was considered to indicate significant differences.

Results

X-ray analysis

The radiographic analysis demonstrated a complete lack of osseous bridging in the control group throughout the entire observation period (Fig. 1A, B). X-rays showed a reliable non-union formation in all control mice with a large persisting gap between the adjoining rounded bone fragments (Fig. 1B). However, in PTH-treated animals the X-rays already indicated first signs of callus formation at 2 weeks after surgery (Fig. 1C) and even osseous bridging in 6 out of 9 (67.7%) animals at 10 weeks after surgery (Fig. 1D). Accordingly, the radiographic analysis revealed a significantly higher Goldberg score in PTH-treated animals at 10 weeks after surgery when compared to controls (0.0 ± 0.0 vs. 1.1 ± 0.3; *p < 0.05 vs. control).

Fig. 1 A–D Representative X-rays of femora of controls (A, B) and PTH-treated mice (C, D) at 2 (A, C) and 10 weeks (B, D) after surgery. Scale bars: 1 mm. Representative µCT-3D reconstructions (E, G, I, K) and transversal µCT images (F, H, J, L) of controls (E–H) and PTH-treated animals (I–L) at 2 (E, F, I, J) and 10 weeks (G, H, K, L) after surgery. Scale bars: 0.5 mm. M, N Poorly (PM) and highly mineralized (HM) bone volume of the callus tissue of controls (white bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) and PTH-treated mice (black bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) at 2 (M) and 10 weeks (N) after surgery, as assessed by µCT analyses. Mean ± SEM; *p < 0.05 vs. control

µCT analysis

In line with our X-ray analysis, µCT imaging showed a lack of osseous bridging in control animals throughout the entire 10-weeks observation period (Fig. 1E–H). In contrast, in the PTH group we observed signs of callus formation already at 2 weeks after surgery (Fig. 1I, J) and successful osseous bridging at 10 weeks after surgery (Fig. 1K, L), indicating an improved bone regeneration. Accordingly, the µCT analysis demonstrated a significantly higher amount of poorly and highly mineralized bone tissue in PTH-treated animals at 2 and 10 weeks after surgery (Fig. 1M, N).

In addition, we found a significantly higher BV/TV and bone surface density in PTH-treated mice at 2 and 10 weeks after surgery when compared to controls (Fig. 2A, B). Further analyses of the trabecular architecture demonstrated a significantly higher trabecular thickness in the PTH group at 2 and 10 weeks after surgery (Fig. 2C). This was associated with a significantly lower trabecular separation and, accordingly, a significantly higher trabecular number in PTH-treated animals when compared to controls throughout the 10-weeks observation period (Fig. 2D, E).

Fig. 2 A–E BV/TV (%) (A), bone surface density (1/mm) (B), trabecular thickness (mm) (C), trabecular separation (mm) (D) and trabecular number (1/mm) (E) of the callus tissue of controls (white bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) and PTH-treated mice (black bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) at 2 and 10 weeks after surgery, as assessed by µCT analyses. F Bending stiffness (N/mm) of femora of controls (white bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) and PTH-treated mice (black bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) at 2 and 10 weeks after surgery, as assessed by biomechanical analysis. Mean ± SEM; *p < 0.05 vs. control

Biomechanical analysis

Femora of PTH-treated mice exhibited a significantly higher bending stiffness at 2 and 10 weeks after surgery when compared to controls (Fig. 2F). Notably, the bending stiffness of femora of control animals remained < 1 N/mm, indicating a complete failure of fracture healing (Fig. 2F).

Histomorphometric and immunohistochemical analysis

Histomorphometric analysis demonstrated a complete lack of osseous bridging in the control group at 2 and 10 weeks after surgery with abundant fibrous tissue between the bone fragments (Fig. 3A, B). In PTH-treated animals, distinct signs of endochondral ossification could be detected at 2 weeks after surgery (Fig. 3C), resulting in osseous bridging at 10 weeks (Fig. 3D). This indicates successful bone regeneration. Quantitative analyses revealed a significantly higher fraction of bone and cartilaginous tissue at 2 weeks after surgery in the PTH group when compared to controls, whereas the fraction of fibrous tissue was significantly lower (Fig. 3E). At 10 weeks, the callus tissue in the control group still consisted mainly of fibrous tissue, whereas in PTH-treated animals it mainly consisted of newly formed bone tissue. Notably, the amount of cartilaginous tissue did not significantly differ between the two study groups at 10 weeks after surgery (Fig. 3F).

Fig. 3 A–D Representative histological images of Safranin-O-stained femora of controls (A, B) and PTH-treated mice (C, D) at 2 (A, C) and 10 weeks (B, D) after surgery. Fibrous tissue (ft), cartilaginous tissue (ct), woven bone (wb) and cortical bone (cb) are indicated. Scale bars: 0.5 mm. E, F Callus composition (%), including fibrous tissue (white), cartilaginous tissue (gray) and osseous tissue (black), of the callus of controls (n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) and PTH-treated mice (n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) at 2 (E) and 10 (F) weeks after surgery, as assessed by histomorphometric analysis. G Representative histological images of TRAP-positive osteoclasts (arrowheads) within the callus tissue of controls and PTH-treated mice at 2 and 10 weeks after surgery. Scale bars: 25 μm. H TRAP-positive osteoclasts/HPF within the callus tissue of controls (white bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) and PTH-treated mice (black bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) at 2 and 10 weeks after surgery, as assessed by histological analysis. Mean ± SEM; *p < 0.05 vs. control

In addition, the analysis of the number of TRAP-positive osteoclasts within the callus tissue, demonstrated a significantly higher number of positive cells in PTH-treated animals at 2 and 10 weeks when compared to controls (Fig. 3G, H). Moreover, the analysis of the vascularization of the callus tissue by immunohistochemical staining of CD31-positive microvessels, demonstrated a slightly higher number of microvessels at 2 weeks after surgery, and a significantly higher number at 10 weeks in the PTH-group when compared to controls (Fig. 4A, B). Furthermore, the analysis of the inflammatory response in the callus tissue by staining MPO-positive granulocytes and CD68-positive macrophages revealed in PTH-treated animals a significantly lower number of MPO-positive granulocytes and CD68-positive macrophages at 2 and 10 weeks after surgery (Fig. 4C–F).

Fig. 4 A Representative immunohistochemical images of CD31-positive microvessels (arrowheads) within the callus tissue of controls and PTH-treated mice at 2 and 10 weeks after surgery. Scale bars: 25 μm. B CD31-positive microvessels/HPF within the callus tissue of controls (white bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) and PTH-treated mice (black bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) at 2 and 10 weeks after surgery, as assessed by immunohistochemical analysis. Mean ± SEM; *p < 0.05 vs. control. C Representative immunohistochemical images of MPO-positive cells (arrowheads) within the callus tissue of controls and PTH-treated mice at 2 and 10 weeks after surgery. Scale bars: 25 μm. D MPO-positive cells/HPF within the callus tissue of controls (white bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) and PTH-treated mice (black bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) at 2 and 10 weeks after surgery, as assessed by immunohistochemical analysis. Mean ± SEM; *p < 0.05 vs. control. E Representative immunohistochemical images of CD68-positive cells (arrowheads) within the callus tissue of controls and PTH-treated mice at 2 and 10 weeks after surgery. Scale bars: 25 μm. F CD68-positive cells/HPF within the callus tissue of controls (white bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) and PTH-treated mice (black bars, n = 5 at 2 weeks after surgery, n = 9 at 10 weeks after surgery) at 2 and 10 weeks after surgery, as assessed by immunohistochemical analysis. Mean ± SEM; *p < 0.05 vs. control

Western blot analysis

Western blot analyses of the callus tissue at 2 weeks after surgery revealed an over twofold higher expression of VEGF in the PTH group when compared to controls. However, this difference did not prove to be statistically significant (Fig. 5A, B). In contrast, the expression of COX2 and PI3K was significantly higher within the callus tissue of PTH-treated mice when compared to controls (Fig. 5A, C, D).

Fig. 5 A Representative Western blots of VEGF, COX-2, PI3K and β-actin expression within the callus tissue of controls and PTH-treated mice at 2 weeks after surgery. B–D Expression of VEGF (pixel intensity × 104) (B), COX-2 (pixel intensity × 104) (C) and PI3K (pixel intensity × 104) (D) within the callus tissue of controls (white bars, n = 3) and PTH-treated mice (black bars, n = 3) at 2 weeks after surgery, as assessed by Western blot analysis. Mean ± SEM; *p < 0.05 vs. control

Discussion

Non-union formation still represents a major complication in trauma and orthopedic surgery, especially in geriatric patients. Therefore, the aim of the present study was to clarify, whether this problem may be overcome by stimulating bone regeneration with PTH. The major findings of the study are that in a murine atrophic non-union model, PTH treatment improves bone formation, resulting in successful osseous bridging at 10 weeks after surgery. This was associated with a higher bending stiffness and an increased vascularization within the callus tissue of femora of PTH-treated animals when compared to controls.

In clinical practice there are variabilities on the definition of delayed healing and non-union formation [24]. Non-unions are defined by the U.S. Federal Drug Administration council as ‘failure to achieve union by 9 months since the injury, and for which there has been no signs of healing for 3 months’ [25]. However, others define non-union formation in long bones after a period of 6 months without radiological signs of fracture healing [25]. In general, it should be considered that the diagnosis of non-union always includes both the radiological and clinical examination of the patient [26].

In the present study, we used the non-union model by Garcia et al. [27], which we recently established in geriatric CD-1 mice [15]. Notably, aging affects the process of bone regeneration by multiple factors, including (i) a decreased differentiation and proliferation of stem cells, (ii) a delay in chondrogenesis and osteochondral ossification as well as (iii) a dysfunction in the bone vascular system [15, 28]. In a recent study, we showed that aged CD-1 mice exhibit a delayed process of callus remodeling and, thus, a delayed fracture healing when compared to young adult animals. Interestingly, the overall healing capacity is not affected by aging, as indicated by the finding that both aged and young adult animals achieve complete femoral bone healing 4 to 5 weeks after fracture [29]. Non-union formation in these animals has been considered as lack of healing for at least 10 weeks [15, 27, 30]. This in line with human femoral fractures, which require around 12 weeks for normal healing and non-union is defined as lack of healing after 24 weeks, thus double of the normal healing period [27]. Our results demonstrate that PTH treatment leads to osseous bridging at 10 weeks after surgery and, therefore, overcomes failed fracture-healing and non-union formation.

As a species on the lower phylogenetic scale, mice possess a great potential for bone repair. Hence, the development of a reliable and reproducible non-union model is highly challenging. Garcia et al. [27] established such a model by creating a critical size femoral defect and performing additional periosteal stripping with subsequent fixation by a ‘pin-clip’ device. Interestingly, in this model a reliable non-union formation was only achieved with additional periosteal stripping after creation of the 1.8 mm femoral defect, whereas animals with intact periosteum demonstrated a partial healing at 10 weeks after surgery [27]. The periosteum is a highly vascularized tissue, which plays a vital role in the process of physiological bone regeneration by providing the cortical blood supply [31] and serves as a reservoir for osteoprogenitor cells [32]. Moreover, it is well known that periosteal stripping impairs fracture healing [33, 34]. These findings may explain the additional deterioration of bone repair after periosteal stripping in the present non-union model.

Fracture healing is characterized by the formation of a soft callus tissue, which gradually transforms into bone by the resorption of calcified cartilage and the formation of novel bone tissue [35, 36]. Interestingly, our histomorphometric analysis showed a significantly higher fraction of cartilaginous tissue in PTH-treated aged animals at 2 weeks after surgery as a clear sign of endochondral ossification. This resulted in the formation of novel bone tissue and osseous bridging at 10 weeks after surgery. In contrast, no signs of endochondral ossification were evident in control animals throughout the 10-weeks observation period. Moreover, the callus tissue of PTH-treated animals showed a significantly higher number of TRAP-positive osteoclasts. Osteoclasts are vital for cartilage resorption and callus remodeling, promoting the formation of mature novel bone tissue [37]. Therefore, it may be assumed that PTH treatment stimulates bone regeneration in aged mice by inducing endochondral ossification and osteoclast-mediated callus remodeling.

Angiogenesis plays a crucial role for fracture repair. In fact, newly formed blood vessels allow the delivery of nutrients to the fracture site and the infiltration of cells that are essential for callus remodeling [38]. The importance of vascularization is also highlighted by several experimental studies demonstrating that the pharmacological inhibition of angiogenesis by TNP-470, nonsteroidal anti-inflammatory drugs or fumagillin impairs fracture repair and eventually leads to non-union formation [39–41]. Interestingly, our immunohistochemical analysis showed an increased number of CD31-positive microvessels within the callus tissue of PTH-treated animals. This was associated with an over twofold higher expression of VEGF in the PTH group when compared to controls. VEGF is recognized as a main growth factor for the stimulation of angiogenesis [42]. Moreover, several studies indicated that VEGF is directly involved in the process of bone regeneration [43, 44]. Accordingly, inhibition of VEGF expression has been shown to impair fracture repair and to result in non-union formation [45], whereas stimulation of VEGF expression can accelerate fracture healing [46]. Notably, the effects of VEGF on fracture repair exceed the sole stimulation of angiogenesis, but also involve the direct stimulation of endochondral and intramembranous fracture healing as well as stem cell recruitment [43, 44]. Therefore, it may be speculated that PTH improves bone regeneration in aged mice not only by the stimulation of vascularization but also by directly inducing novel bone formation.

The inflammatory phase is a crucial part of successful bone regeneration, as neutrophilic granulocytes and macrophages remove injured and devitalized tissue within the callus and mesenchymal stem cells are directed to the fracture site [37, 47]. A dysregulated, perturbated or even chronic inflammation, however, can impair the process of bone regeneration and even lead to healing failure [48, 49]. Aged individuals exhibit higher levels of circulating pro-inflammatory cytokines, resulting in a chronic inflammatory status, referred to as “inflamm-aging” [50]. Accordingly, we previously detected an increased number of pro-inflammatory macrophages within the callus tissue of non-unions in aged mice when compared to young animals [51]. Moreover, in the present study our immunohistochemical analysis demonstrated that the improved bone regeneration in PTH-treated animals is associated with a significantly lowered number of neutrophilic granulocytes and macrophages within the callus tissue. In line with these findings, Clark et al. [28] recently showed that the inhibition of macrophage recruitment results in improved fracture healing with increased bone volume in aged mice. Thus, PTH treatment most likely inhibits the overshooting inflammatory response in non-unions of aged mice by reducing the number of granulocytes and macrophages within the callus, leading to the observed improved bone regeneration.

Cyclooxygenases (COXs) are necessary for the generation of prostaglandins, prostacyclins and thromboxanes during inflammation. Notably, COX-2 is highly expressed in chondrocytes and chondroprogenitors during the early stage of bone repair [52]. Moreover, Naik et al. [53] observed a delayed bone remodeling in aged mice with a decreased COX-2 expression during the early inflammatory phase of bone repair, highlighting the crucial role of COX-2 in bone healing. In the present study, Western blot analyses demonstrated during the early healing period of 2 weeks a significantly increased expression of COX-2 in PTH-treated mice. Hence, these findings indicate that PTH-treatment improves bone regeneration in aged mice by upregulating COX-2 expression within the callus tissue during the early stage of healing.

PI3K signaling is a pathway activated through receptor tyrosine kinases (RTKs) and G-protein coupled receptors, playing a vital role in cell metabolism and proliferation as well as the regulation of gene expression [54]. Moreover, there is evidence that PI3K signaling is directly involved in the regulation of osteoblastogenesis and skeletal remodeling by controlling osteoblast proliferation and differentiation [55]. Furthermore, Scanlon et al. [56] recently reported that knock-in mice with a global increase in PI3K signaling (gCblYF) exhibit an improved femoral bone healing, which is characterized by an enhanced proliferation of periosteal cells during the first days of fracture repair. In the present study, we found a significantly increased expression of PI3K within the callus tissue of aged PTH-treated mice. Therefore, it may be speculated that the improved bone healing observed in PTH-treated animals is mediated in part also by the activation of PI3K signaling.

In summary, our results demonstrate that PTH treatment significantly improves the regeneration of atrophic non-unions in aged mice. This was associated with an increased number of osteoclasts and CD31-positive microvessels as well as an enhanced expression of COX-2 and PI3K within the callus tissue of PTH-treated animals during the early healing phase. As PTH is a clinically approved drug [13], it may be a promising candidate for the future treatment of non-union formation in aged patients.

Acknowledgements

We are grateful for the excellent technical assistance of Sandra Hans and Caroline Bickelmann.

Author contributions

MMM: data analysis, figure preparation, data discussion and interpretation, manuscript writing. ALT: surgery, radiological, biomechanical and histological analysis. DB: surgery, radiological analysis. MB: surgery, radiological analysis. CS: Western blot analysis. MDM, TH: idea and study design, data interpretation, manuscript writing. MWL: idea and study design, data discussion and interpretation, critical manuscript revision. All authors reviewed and approved the final version of the manuscript.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Availability of data and materials

The datasets during and/or analyzed during the current study available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

The original version of this article was revised: There is a spelling mistake in the abstract and body text of the article. It is now: 200 mg/kg. It should be: 200 μg/kg.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Change history

9/9/2024

A Correction to this paper has been published: 10.1186/s12967-024-05594-w
==== Refs
References

1. Einhorn TA Gerstenfeld LC Fracture healing: mechanisms and interventions Nat Rev Rheumatol 2015 11 1 45 54 10.1038/nrrheum.2014.164 25266456
Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2015;11(1):45–54.25266456 10.1038/nrrheum.2014.164
2. Victoria G Bone stimulation for fracture healing: what’s all the fuss? Indian J Orthop 2009 43 2 117 120 10.4103/0019-5413.50844 19838359
Victoria G, et al. Bone stimulation for fracture healing: what’s all the fuss? Indian J Orthop. 2009;43(2):117–20.19838359 10.4103/0019-5413.50844
3. Clark D Effects of aging on fracture healing Curr Osteoporos Rep 2017 15 6 601 608 10.1007/s11914-017-0413-9 29143915
Clark D, et al. Effects of aging on fracture healing. Curr Osteoporos Rep. 2017;15(6):601–8.29143915 10.1007/s11914-017-0413-9
4. Gruber R Fracture healing in the elderly patient Exp Gerontol 2006 41 11 1080 1093 10.1016/j.exger.2006.09.008 17092679
Gruber R, et al. Fracture healing in the elderly patient. Exp Gerontol. 2006;41(11):1080–93.17092679 10.1016/j.exger.2006.09.008
5. Bergman RJ Age-related changes in osteogenic stem cells in mice J Bone Miner Res 1996 11 5 568 577 10.1002/jbmr.5650110504 9157771
Bergman RJ, et al. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res. 1996;11(5):568–77.9157771 10.1002/jbmr.5650110504
6. Lu C Cellular basis for age-related changes in fracture repair J Orthop Res 2005 23 6 1300 1307 10.1016/j.orthres.2005.04.003.1100230610 15936915
Lu C, et al. Cellular basis for age-related changes in fracture repair. J Orthop Res. 2005;23(6):1300–7.15936915 10.1016/j.orthres.2005.04.003.1100230610
7. Robinson CM Estimating the risk of nonunion following nonoperative treatment of a clavicular fracture J Bone Joint Surg Am 2004 86 7 1359 1365 10.2106/00004623-200407000-00002 15252081
Robinson CM, et al. Estimating the risk of nonunion following nonoperative treatment of a clavicular fracture. J Bone Joint Surg Am. 2004;86(7):1359–65.15252081 10.2106/00004623-200407000-00002
8. Parker MJ Raghavan R Gurusamy K Incidence of fracture-healing complications after femoral neck fractures Clin Orthop Relat Res 2007 458 175 179 10.1097/BLO.0b013e3180325a42 17224836
Parker MJ, Raghavan R, Gurusamy K. Incidence of fracture-healing complications after femoral neck fractures. Clin Orthop Relat Res. 2007;458:175–9.17224836 10.1097/BLO.0b013e3180325a42
9. Wojda SJ Donahue SW Parathyroid hormone for bone regeneration J Orthop Res 2018 36 10 2586 2594 10.1002/jor.24075 29926970
Wojda SJ, Donahue SW. Parathyroid hormone for bone regeneration. J Orthop Res. 2018;36(10):2586–94.29926970 10.1002/jor.24075
10. McSheehy PM Chambers TJ Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone Endocrinology 1986 118 2 824 828 10.1210/endo-118-2-824 3455914
McSheehy PM, Chambers TJ. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology. 1986;118(2):824–8.3455914 10.1210/endo-118-2-824
11. Andreassen TT Ejersted C Oxlund H Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures J Bone Miner Res 1999 14 6 960 968 10.1359/jbmr.1999.14.6.960 10352105
Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res. 1999;14(6):960–8.10352105 10.1359/jbmr.1999.14.6.960
12. Komatsubara S Human parathyroid hormone (1–34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora Bone 2005 36 4 678 687 10.1016/j.bone.2005.02.002 15781006
Komatsubara S, et al. Human parathyroid hormone (1–34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone. 2005;36(4):678–87.15781006 10.1016/j.bone.2005.02.002
13. Milstrey A Dose-dependent effect of parathyroid hormone on fracture healing and bone formation in mice J Surg Res 2017 220 327 335 10.1016/j.jss.2017.07.019 29180199
Milstrey A, et al. Dose-dependent effect of parathyroid hormone on fracture healing and bone formation in mice. J Surg Res. 2017;220:327–35.29180199 10.1016/j.jss.2017.07.019
14. Andreassen TT Cacciafesta V Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects J Craniofac Surg 2004 15 3 424 7 10.1097/00001665-200405000-00014 15111801
Andreassen TT, Cacciafesta V. Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects. J Craniofac Surg. 2004;15(3):424–7.15111801 10.1097/00001665-200405000-00014
15. Menger MM Establishment of a reliable model to study the failure of fracture healing in aged mice J Gerontol A Biol Sci Med Sci 2022 77 5 909 917 10.1093/gerona/glab304 34626193
Menger MM, et al. Establishment of a reliable model to study the failure of fracture healing in aged mice. J Gerontol A Biol Sci Med Sci. 2022;77(5):909–17.34626193 10.1093/gerona/glab304
16. Homburger F Aging changes in CD-1 HaM/ICR mice reared under standard laboratory conditions J Natl Cancer Inst 1975 55 1 37 45 10.1093/jnci/55.1.37 169366
Homburger F, et al. Aging changes in CD-1 HaM/ICR mice reared under standard laboratory conditions. J Natl Cancer Inst. 1975;55(1):37–45.169366 10.1093/jnci/55.1.37
17. Goldberg VM Bone grafting: role of histocompatibility in transplantation J Orthop Res 1985 3 4 389 404 10.1002/jor.1100030401 3906062
Goldberg VM, et al. Bone grafting: role of histocompatibility in transplantation. J Orthop Res. 1985;3(4):389–404.3906062 10.1002/jor.1100030401
18. Bosemark P Augmentation of autologous bone graft by a combination of bone morphogenic protein and bisphosphonate increased both callus volume and strength Acta Orthop 2013 84 1 106 111 10.3109/17453674.2013.773123 23409846
Bosemark P, et al. Augmentation of autologous bone graft by a combination of bone morphogenic protein and bisphosphonate increased both callus volume and strength. Acta Orthop. 2013;84(1):106–11.23409846 10.3109/17453674.2013.773123
19. Morgan EF Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function Bone 2009 44 2 335 344 10.1016/j.bone.2008.10.039 19013264
Morgan EF, et al. Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function. Bone. 2009;44(2):335–44.19013264 10.1016/j.bone.2008.10.039
20. Histing T Ex vivo analysis of rotational stiffness of different osteosynthesis techniques in mouse femur fracture J Orthop Res 2009 27 9 1152 1156 10.1002/jor.20849 19215028
Histing T, et al. Ex vivo analysis of rotational stiffness of different osteosynthesis techniques in mouse femur fracture. J Orthop Res. 2009;27(9):1152–6.19215028 10.1002/jor.20849
21. Kawamoto T Kawamoto K Preparation of thin frozen sections from nonfixed and undecalcified hard tissues using Kawamot’s film method (2012) Methods Mol Biol 2014 1130 149 164 10.1007/978-1-62703-989-5_11 24482171
Kawamoto T, Kawamoto K. Preparation of thin frozen sections from nonfixed and undecalcified hard tissues using Kawamot’s film method (2012). Methods Mol Biol. 2014;1130:149–64.24482171 10.1007/978-1-62703-989-5_11
22. Morodomi Y Modified application of Kawamoto’s film method for super-resolution imaging of megakaryocytes in undecalcified bone marrow Res Pract Thromb Haemost 2020 4 1 86 91 10.1002/rth2.12276 31989088
Morodomi Y, et al. Modified application of Kawamoto’s film method for super-resolution imaging of megakaryocytes in undecalcified bone marrow. Res Pract Thromb Haemost. 2020;4(1):86–91.31989088 10.1002/rth2.12276
23. Gerstenfeld LC Application of histomorphometric methods to the study of bone repair J Bone Miner Res 2005 20 10 1715 1722 10.1359/JBMR.050702 16160729
Gerstenfeld LC, et al. Application of histomorphometric methods to the study of bone repair. J Bone Miner Res. 2005;20(10):1715–22.16160729 10.1359/JBMR.050702
24. Menger MM Vascularization strategies in the prevention of non-union formation Tissue Eng Part B Rev 2020 27 107 132 10.1089/ten.teb.2020.0111 32635857
Menger MM, et al. Vascularization strategies in the prevention of non-union formation. Tissue Eng Part B Rev. 2020;27:107–32.32635857 10.1089/ten.teb.2020.0111
25. Andrzejowski P Giannoudis PV The ‘diamond concept’ for long bone non-union management J Orthop Traumatol 2019 20 1 21 10.1186/s10195-019-0528-0 30976944
Andrzejowski P, Giannoudis PV. The ‘diamond concept’ for long bone non-union management. J Orthop Traumatol. 2019;20(1):21.30976944 10.1186/s10195-019-0528-0
26. Hak DJ Delayed union and nonunions: epidemiology, clinical issues, and financial aspects Injury 2014 45 Suppl 2 S3 S7 10.1016/j.injury.2014.04.002 24857025
Hak DJ, et al. Delayed union and nonunions: epidemiology, clinical issues, and financial aspects. Injury. 2014;45(Suppl 2):S3–7.24857025 10.1016/j.injury.2014.04.002
27. Garcia P Development of a reliable non-union model in mice J Surg Res 2008 147 1 84 91 10.1016/j.jss.2007.09.013 18061614
Garcia P, et al. Development of a reliable non-union model in mice. J Surg Res. 2008;147(1):84–91.18061614 10.1016/j.jss.2007.09.013
28. Clark D Age-related changes to macrophages are detrimental to fracture healing in mice Aging Cell 2020 19 3 e13112 10.1111/acel.13112 32096907
Clark D, et al. Age-related changes to macrophages are detrimental to fracture healing in mice. Aging Cell. 2020;19(3): e13112.32096907 10.1111/acel.13112
29. Menger MM Radiographic, biomechanical and histological characterization of femoral fracture healing in aged CD-1 mice Bioengineering 2023 10 2 275 10.3390/bioengineering10020275 36829769
Menger MM, et al. Radiographic, biomechanical and histological characterization of femoral fracture healing in aged CD-1 mice. Bioengineering. 2023;10(2):275.36829769 10.3390/bioengineering10020275
30. Garcia P Rodent animal models of delayed bone healing and non-union formation: a comprehensive review Eur Cell Mater 2013 26 1 12 10.22203/eCM.v026a01 23857280
Garcia P, et al. Rodent animal models of delayed bone healing and non-union formation: a comprehensive review. Eur Cell Mater. 2013;26:1–12 (discussion 12–4).23857280 10.22203/eCM.v026a01
31. Squier CA Ghoneim S Kremenak CR Ultrastructure of the periosteum from membrane bone J Anat 1990 171 233 239 2081707
Squier CA, Ghoneim S, Kremenak CR. Ultrastructure of the periosteum from membrane bone. J Anat. 1990;171:233–9.2081707
32. Arnsdorf EJ The periosteum as a cellular source for functional tissue engineering Tissue Eng Part A 2009 15 9 2637 2642 10.1089/ten.tea.2008.0244 19207046
Arnsdorf EJ, et al. The periosteum as a cellular source for functional tissue engineering. Tissue Eng Part A. 2009;15(9):2637–42.19207046 10.1089/ten.tea.2008.0244
33. Utvag SE Grundnes O Reikeraos O Effects of periosteal stripping on healing of segmental fractures in rats J Orthop Trauma 1996 10 4 279 284 10.1097/00005131-199605000-00009 8723407
Utvag SE, Grundnes O, Reikeraos O. Effects of periosteal stripping on healing of segmental fractures in rats. J Orthop Trauma. 1996;10(4):279–84.8723407 10.1097/00005131-199605000-00009
34. Oni OO Stafford H Gregg PJ An experimental study of the patterns of periosteal and endosteal damage in tibial shaft fractures using a rabbit trauma model J Orthop Trauma 1989 3 2 142 147 10.1097/00005131-198906000-00009 2738762
Oni OO, Stafford H, Gregg PJ. An experimental study of the patterns of periosteal and endosteal damage in tibial shaft fractures using a rabbit trauma model. J Orthop Trauma. 1989;3(2):142–7.2738762 10.1097/00005131-198906000-00009
35. Marsell R Einhorn TA The role of endogenous bone morphogenetic proteins in normal skeletal repair Injury 2009 40 Suppl 3 S4 S7 10.1016/S0020-1383(09)70003-8 20082790
Marsell R, Einhorn TA. The role of endogenous bone morphogenetic proteins in normal skeletal repair. Injury. 2009;40(Suppl 3):S4–7.20082790 10.1016/S0020-1383(09)70003-8
36. Histing T Pantoprazole, a proton pump inhibitor, delays fracture healing in mice Calcif Tissue Int 2012 90 6 507 514 10.1007/s00223-012-9601-x 22527206
Histing T, et al. Pantoprazole, a proton pump inhibitor, delays fracture healing in mice. Calcif Tissue Int. 2012;90(6):507–14.22527206 10.1007/s00223-012-9601-x
37. Bahney CS Cellular biology of fracture healing J Orthop Res 2019 37 1 35 50 10.1002/jor.24170 30370699
Bahney CS, et al. Cellular biology of fracture healing. J Orthop Res. 2019;37(1):35–50.30370699 10.1002/jor.24170
38. Schlundt C Clinical and Research approaches to treat non-union fracture Curr Osteoporos Rep 2018 16 2 155 168 10.1007/s11914-018-0432-1 29536393
Schlundt C, et al. Clinical and Research approaches to treat non-union fracture. Curr Osteoporos Rep. 2018;16(2):155–68.29536393 10.1007/s11914-018-0432-1
39. Fang TD Angiogenesis is required for successful bone induction during distraction osteogenesis J Bone Miner Res 2005 20 7 1114 1124 10.1359/JBMR.050301 15940364
Fang TD, et al. Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res. 2005;20(7):1114–24.15940364 10.1359/JBMR.050301
40. Murnaghan M Li G Marsh DR Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis? J Bone Jt Surg Am 2006 88 Suppl 3 140 147
Murnaghan M, Li G, Marsh DR. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis? J Bone Jt Surg Am. 2006;88(Suppl 3):140–7.
41. Fassbender M Local inhibition of angiogenesis results in an atrophic non-union in a rat osteotomy model Eur Cell Mater 2011 22 1 11 10.22203/eCM.v022a01 21732278
Fassbender M, et al. Local inhibition of angiogenesis results in an atrophic non-union in a rat osteotomy model. Eur Cell Mater. 2011;22:1–11.21732278 10.22203/eCM.v022a01
42. Garcia P Temporal and spatial vascularization patterns of unions and nonunions: role of vascular endothelial growth factor and bone morphogenetic proteins J Bone Joint Surg Am 2012 94 1 49 58 10.2106/JBJS.J.00795 22218382
Garcia P, et al. Temporal and spatial vascularization patterns of unions and nonunions: role of vascular endothelial growth factor and bone morphogenetic proteins. J Bone Joint Surg Am. 2012;94(1):49–58.22218382 10.2106/JBJS.J.00795
43. Beamer B Hettrich C Lane J Vascular endothelial growth factor: an essential component of angiogenesis and fracture healing HSS J 2010 6 1 85 94 10.1007/s11420-009-9129-4 19763695
Beamer B, Hettrich C, Lane J. Vascular endothelial growth factor: an essential component of angiogenesis and fracture healing. HSS J. 2010;6(1):85–94.19763695 10.1007/s11420-009-9129-4
44. Keramaris NC Fracture vascularity and bone healing: a systematic review of the role of VEGF Injury 2008 39 Suppl 2 S45 S57 10.1016/S0020-1383(08)70015-9 18804573
Keramaris NC, et al. Fracture vascularity and bone healing: a systematic review of the role of VEGF. Injury. 2008;39(Suppl 2):S45–57.18804573 10.1016/S0020-1383(08)70015-9
45. Gaston MS Simpson AH Inhibition of fracture healing J Bone Jt Surg Br 2007 89 12 1553 1560 10.1302/0301-620X.89B12.19671
Gaston MS, Simpson AH. Inhibition of fracture healing. J Bone Jt Surg Br. 2007;89(12):1553–60.10.1302/0301-620X.89B12.19671
46. Peng H VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis J Bone Miner Res 2005 20 11 2017 2027 10.1359/JBMR.050708 16234975
Peng H, et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res. 2005;20(11):2017–27.16234975 10.1359/JBMR.050708
47. Medhat D Rodriguez CI Infante A Immunomodulatory effects of MSCs in bone healing Int J Mol Sci 2019 20 21 5467 10.3390/ijms20215467 31684035
Medhat D, Rodriguez CI, Infante A. Immunomodulatory effects of MSCs in bone healing. Int J Mol Sci. 2019;20(21):5467.31684035 10.3390/ijms20215467
48. Loi F Inflammation, fracture and bone repair Bone 2016 86 119 130 10.1016/j.bone.2016.02.020 26946132
Loi F, et al. Inflammation, fracture and bone repair. Bone. 2016;86:119–30.26946132 10.1016/j.bone.2016.02.020
49. Hankenson KD Zimmerman G Marcucio R Biological perspectives of delayed fracture healing Injury 2014 45 Suppl 2 S8 S15 10.1016/j.injury.2014.04.003 24857030
Hankenson KD, Zimmerman G, Marcucio R. Biological perspectives of delayed fracture healing. Injury. 2014;45(Suppl 2):S8–15.24857030 10.1016/j.injury.2014.04.003
50. Franceschi C Inflamm-aging. An evolutionary perspective on immunosenescence Ann N Y Acad Sci 2000 908 244 254 10.1111/j.1749-6632.2000.tb06651.x 10911963
Franceschi C, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–54.10911963 10.1111/j.1749-6632.2000.tb06651.x
51. Menger MM Establishment of a reliable model to study the failure of fracture healing in aged mice J Gerontol A Biol Sci Med Sci 2021 77 909 917 10.1093/gerona/glab304
Menger MM, et al. Establishment of a reliable model to study the failure of fracture healing in aged mice. J Gerontol A Biol Sci Med Sci. 2021;77:909–17.10.1093/gerona/glab304
52. Xie C COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing Bone 2008 43 6 1075 1083 10.1016/j.bone.2008.08.109 18773980
Xie C, et al. COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. Bone. 2008;43(6):1075–83.18773980 10.1016/j.bone.2008.08.109
53. Naik AA Reduced COX-2 expression in aged mice is associated with impaired fracture healing J Bone Miner Res 2009 24 2 251 264 10.1359/jbmr.081002 18847332
Naik AA, et al. Reduced COX-2 expression in aged mice is associated with impaired fracture healing. J Bone Miner Res. 2009;24(2):251–64.18847332 10.1359/jbmr.081002
54. Cantley LC The phosphoinositide 3-kinase pathway Science 2002 296 5573 1655 1657 10.1126/science.296.5573.1655 12040186
Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296(5573):1655–7.12040186 10.1126/science.296.5573.1655
55. Guntur AR Rosen CJ The skeleton: a multi-functional complex organ: new insights into osteoblasts and their role in bone formation: the central role of PI3Kinase J Endocrinol 2011 211 2 123 130 10.1530/JOE-11-0175 21673026
Guntur AR, Rosen CJ. The skeleton: a multi-functional complex organ: new insights into osteoblasts and their role in bone formation: the central role of PI3Kinase. J Endocrinol. 2011;211(2):123–30.21673026 10.1530/JOE-11-0175
56. Scanlon V Loss of Cbl-PI3K interaction modulates the periosteal response to fracture by enhancing osteogenic commitment and differentiation Bone 2017 95 124 135 10.1016/j.bone.2016.11.020 27884787
Scanlon V, et al. Loss of Cbl-PI3K interaction modulates the periosteal response to fracture by enhancing osteogenic commitment and differentiation. Bone. 2017;95:124–35.27884787 10.1016/j.bone.2016.11.020
